ArticleAmerican journal of translational research2026
Threshold-dependent effect of the neutrophil-to-albumin ratio (NAR) in early pregnancy: a novel insight for preeclampsia risk prediction.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePreeclampsia (PE) is a major cause of adverse outcomes in pregnant, postpartum, and perinatal women; however, its early identification remains a clinical challenge, particularly in resource-scarce regions. The neutrophil-to-albumin ratio (NAR) reflects both systemic inflammatory response and nutritional status and has recently emerged as a promising early biomarker. This study aimed to investigate the association between NAR and subsequent PE risk and to compare its predictive efficacy with that of placental growth factor (PlGF) and mean arterial pressure (MAP).
methodsThis retrospective cohort study enrolled 11,916 pregnant women with a gestational age of < 14 weeks. Logistic regression, restricted cubic spline (RCS), and two-stage regression analyses were applied to assess the association between NAR and PE. The diagnostic performance of NAR, PlGF, and MAP was compared using receiver operating characteristic (ROC) curve analysis.
resultsAfter adjustment for maternal factors, elevated NAR was independently associated with an increased risk of PE (adjusted odds ratio [OR] = 2.04; 95% confidence interval [CI]: 1.42-2.92; P < 0.001). RCS analysis identified a nonlinear threshold at log-transformed NAR (LN[NAR]) = -1.92, beyond which PE risk increased sharply (OR = 4.26; 95% CI: 1.99-9.13). LN(NAR) and PlGF demonstrated comparable discriminative ability (area under the curve [AUC] = 0.591 vs. 0.605) but were inferior to MAP (AUC = 0.710). The correlation between NAR and PlGF was weak (r = 0.05).
conclusionElevated LN(NAR) is independently associated with PE in a threshold-dependent manner. In resource-limited settings, NAR may serve as a practical early PE biomarker for PE or as a component of multimodal prediction models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.